About Cocrystal Pharma

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. We employ unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies are designed to efficiently deliver small molecule therapeutics that are safe, effective, and convenient to administer. We have identified promising preclinical antiviral therapeutics that target the replication process of influenza virus, SARS-CoV-2 virus, and norovirus. We have completed enrollment in a Phase 1 clinical trial targeting pandemic and seasonal influenza A and have completed a Phase 2a trial targeting the hepatitis C virus.

Our Team